Naringenin

DIETARY_SUPPLEMENT2 trials

Sponsors

Massachusetts General Hospital, Pennington Biomedical Research Center

Conditions

Chronic HCVHCV InfectionHepatitis CHepatitis C VirusPharmacokineticsSafety Issues

Early Phase 1

Safety and Pharmacokinetics of an Extract of Naringenin

CompletedNCT03582553

Pennington Biomedical Research CenterPharmacokinetics, Safety Issues

Start: 2018-05-25End: 2018-09-28Updated: 2020-01-18

Phase 1

A Pilot Study of the Grapefruit Flavonoid Naringenin for HCV Infection

CompletedNCT01091077

Massachusetts General HospitalChronic HCV, HCV Infection, Hepatitis C +1

Start: 2009-06-30End: 2013-08-31Updated: 2015-09-23